59 (40)% (38)% Core EBIT 141 148 231 (5)% (39)% Core Net Profit after Tax and NCI4 82 50 159 64% (48)% Core Net Profit after Tax and NCI (THB m) 2,609 1,562 5,027 67% (48)% Core EPS after PERP Interest
)% Integrated Oxides and Derivatives 50 31 3 64% 1,893% Fibers 61 43 69 43% (12)% Core EBIT 148 54 178 176% (17)% Core Net Profit after Tax and NCI4 50 8 128 514% (61)% Core Net Profit after Tax and NCI (THB m
Concentration 2.5. NPAs Concentration by Region by Type 3. Key Financial Ratios 4. Forward Looking Statement 4.1. BAM’s Business Opportunity 4.2. COVID-19 Impact 4.3. Land and Building Tax 1. Key Highlights in Q2
increase of 13.1%, due to an increase in purchase tax and unpaid tax for the project has already been implemented but not yet delivered. In addition, gains from forward contracts due to forward exchange
from deferred tax for the amount of THB 28.6 million. The net amount after amortization was 24.1 million in year 2017 Revenue from Hospital Operations Revenue from hospital operations in the fourth
0.22 2.55 Profit before financing costs and income tax expense 34.53 14.26 37.76 15.55 24.46 14.13 13.30 54.37 Financing cost 11.22 4.63 10.05 4.14 2.87 1.66 7.18 250.17 Profit before income tax expense
13.03 0.19 1.82 -2.41 -18.50 21.05 22.78 -1.73 -7.59 Financial Cost 0.22 0.22 1.89 - - -1.67 -88.36 0.45 3.16 -2.71 -85.76 Profit (loss) before income tax expenses -14.29 -15.87 -23.78 1.58 -9.96 9.49
660.50 83.17% 1,303.52 139.15% -643.02 -49.33% Profit before finance costs and income tax expense 133.69 16.83% -366.74 -39.15% 500.42 -136.45% Finance costs 36.13 4.55% 45.56 4.86% -9.43 -20.69% Profit
% Administrative expenses 25.60 30.62 -5.02 -16.40% Reversal of doubtful debts -3.34 - -3.34 100.00% Total expenses 230.04 108.41 121.63 112.19% Profit before finance costs and income tax expenses -1.35 9.69 - 11.03